Variant report

Variant	nsv591300
Chromosome Location	chr3:112144026-112270857
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1661)
CpG islands
(count:244)
Chromatin interactive
region (count:39)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:1661 , 50 per page) page: 1 2 3 4 5 6 7 ... 34

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:112250371-112250382	K562	blood:	n/a	n/a
2	ARID3A	chr3:112250194-112250459	HepG2	liver:	n/a	n/a
3	ATF2	chr3:112174716-112175428	GM12878	blood:	n/a	n/a
4	ATF2	chr3:112217577-112218762	GM12878	blood:	n/a	n/a
5	ATF2	chr3:112208326-112210333	GM12878	blood:	n/a	n/a
6	ATF2	chr3:112191977-112192593	GM12878	blood:	n/a	n/a
7	ATF2	chr3:112237760-112238685	GM12878	blood:	n/a	n/a
8	ATF2	chr3:112202984-112203674	GM12878	blood:	n/a	n/a
9	ATF2	chr3:112174606-112175451	GM12878	blood:	n/a	n/a
10	ATF2	chr3:112182945-112183787	GM12878	blood:	n/a	n/a
11	ATF2	chr3:112208191-112210297	GM12878	blood:	n/a	n/a
12	ATF2	chr3:112258649-112259179	GM12878	blood:	n/a	n/a
13	ATF2	chr3:112178323-112180365	GM12878	blood:	n/a	n/a
14	ATF2	chr3:112181801-112183834	GM12878	blood:	n/a	n/a
15	ATF2	chr3:112233307-112233940	GM12878	blood:	n/a	n/a
16	ATF2	chr3:112217882-112218686	GM12878	blood:	n/a	n/a
17	ATF2	chr3:112258495-112259308	GM12878	blood:	n/a	n/a
18	ATF2	chr3:112181963-112182703	GM12878	blood:	n/a	n/a
19	ATF2	chr3:112178586-112180203	GM12878	blood:	n/a	n/a
20	ATF2	chr3:112233216-112233958	GM12878	blood:	n/a	n/a
21	ATF2	chr3:112201412-112201996	GM12878	blood:	n/a	n/a
22	BATF	chr3:112183210-112183468	GM12878	blood:	n/a	n/a
23	BATF	chr3:112222377-112222753	GM12878	blood:	n/a	n/a
24	BATF	chr3:112258695-112259018	GM12878	blood:	n/a	n/a
25	BATF	chr3:112179396-112179832	GM12878	blood:	n/a	chr3:112179585-112179594
26	BATF	chr3:112179289-112179926	GM12878	blood:	n/a	chr3:112179889-112179899 chr3:112179585-112179594
27	BATF	chr3:112233345-112233906	GM12878	blood:	n/a	n/a
28	BATF	chr3:112233387-112233955	GM12878	blood:	n/a	n/a
29	BATF	chr3:112178649-112178996	GM12878	blood:	n/a	n/a
30	BATF	chr3:112180623-112180947	GM12878	blood:	n/a	chr3:112180796-112180807
31	BATF	chr3:112208785-112209113	GM12878	blood:	n/a	n/a
32	BATF	chr3:112208739-112209174	GM12878	blood:	n/a	n/a
33	BATF	chr3:112183149-112183504	GM12878	blood:	n/a	n/a
34	BCL11A	chr3:112192183-112192464	GM12878	blood:	n/a	n/a
35	BCL11A	chr3:112233338-112233797	GM12878	blood:	n/a	n/a
36	BCL11A	chr3:112233466-112233775	GM12878	blood:	n/a	n/a
37	BCL11A	chr3:112179271-112179712	GM12878	blood:	n/a	chr3:112179524-112179533
38	BCL11A	chr3:112183088-112183485	GM12878	blood:	n/a	n/a
39	BCL11A	chr3:112208757-112209201	GM12878	blood:	n/a	n/a
40	BCL11A	chr3:112179330-112179886	GM12878	blood:	n/a	chr3:112179524-112179533
41	BCL11A	chr3:112178672-112178956	GM12878	blood:	n/a	n/a
42	BCL3	chr3:112245548-112245831	GM12878	blood:	n/a	n/a
43	BCL3	chr3:112192167-112192475	GM12878	blood:	n/a	n/a
44	BCL3	chr3:112233334-112233931	GM12878	blood:	n/a	n/a
45	BCL3	chr3:112183082-112183515	GM12878	blood:	n/a	n/a
46	BCL3	chr3:112210835-112211375	GM12878	blood:	n/a	n/a
47	BCL3	chr3:112174642-112175427	GM12878	blood:	n/a	n/a
48	BCL3	chr3:112179382-112180021	GM12878	blood:	n/a	chr3:112179524-112179533
49	BCL3	chr3:112178509-112180324	GM12878	blood:	n/a	chr3:112179524-112179533
50	BCL3	chr3:112208669-112209195	GM12878	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:112184271-112184321	BE2_C	brain:	n/a
2	chr3:112184271-112184321	CMK	blood:	n/a
3	chr3:112217973-112218023	SK-N-MC	brain:	n/a
4	chr3:112184271-112184321	AG09309	skin:	n/a
5	chr3:112218510-112218560	GM12878	blood:	n/a
6	chr3:112218510-112218560	AG04450	lung:	fetal
7	chr3:112218761-112218811	PrEC	prostate:	n/a
8	chr3:112217973-112218023	AG10803	skin:	n/a
9	chr3:112184271-112184321	SKMC	muscle:	n/a
10	chr3:112217973-112218023	PrEC	prostate:	n/a
11	chr3:112217973-112218023	Hela-S3	cervix:	n/a
12	chr3:112218761-112218811	AG09309	skin:	n/a
13	chr3:112217973-112218023	AG04450	lung:	fetal
14	chr3:112184271-112184321	AG04450	lung:	fetal
15	chr3:112218761-112218811	HL-60	blood:	n/a
16	chr3:112217973-112218023	Jurkat	blood:	n/a
17	chr3:112184271-112184321	HUVEC	blood vessel:	n/a
18	chr3:112184271-112184321	NHBE	bronchial:	n/a
19	chr3:112218761-112218811	HPAEpiC	pulmonary alveolar:	n/a
20	chr3:112218510-112218560	HEK293	kidney:	embryo
21	chr3:112184271-112184321	MCF-7	breast:	n/a
22	chr3:112218761-112218811	MCF-7	breast:	n/a
23	chr3:112218761-112218811	PANC-1	pancreas:	n/a
24	chr3:112218761-112218811	H1-hESC	embryonic stem cell:	embryo
25	chr3:112218761-112218811	NHBE	bronchial:	n/a
26	chr3:112184271-112184321	HMEC	breast:	n/a
27	chr3:112218510-112218560	GM19239	blood:	n/a
28	chr3:112184271-112184321	MCF10A-Er-Src	breast:	n/a
29	chr3:112217973-112218023	AG04449	skin:	fetal
30	chr3:112218510-112218560	HRPEpiC	eye:	n/a
31	chr3:112218761-112218811	HMEC	breast:	n/a
32	chr3:112218761-112218811	MCF10A-Er-Src	breast:	n/a
33	chr3:112217973-112218023	H1-hESC	embryonic stem cell:	embryo
34	chr3:112184271-112184321	GM06990	blood:	n/a
35	chr3:112217973-112218023	GM19239	blood:	n/a
36	chr3:112217973-112218023	SK-N-SH	brain:	n/a
37	chr3:112217973-112218023	MCF10A-Er-Src	breast:	n/a
38	chr3:112218761-112218811	AoSMC	blood vessel:	n/a
39	chr3:112218761-112218811	HEEpiC	esophagus:	n/a
40	chr3:112218761-112218811	SK-N-SH_RA	brain:	n/a
41	chr3:112218510-112218560	NHBE	bronchial:	n/a
42	chr3:112218761-112218811	HUVEC	blood vessel:	n/a
43	chr3:112217973-112218023	AG09309	skin:	n/a
44	chr3:112218761-112218811	AG10803	skin:	n/a
45	chr3:112184271-112184321	HEK293	kidney:	embryo
46	chr3:112217973-112218023	HRPEpiC	eye:	n/a
47	chr3:112217973-112218023	ECC-1	luminal epithelium:	n/a
48	chr3:112217973-112218023	GM12878	blood:	n/a
49	chr3:112218761-112218811	A549	lung:	n/a
50	chr3:112218761-112218811	T-47D	breast:	n/a

(count:39 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:112257894..112260182-chr3:112261876..112264065,2	K562	blood:
2	chr3:112263776..112266083-chr3:112359451..112361414,2	MCF-7	breast:
3	chr3:112253284..112253915-chr3:126107853..126108632,2	MCF-7	breast:
4	chr3:111855697..111856656-chr3:112238008..112238836,2	K562	blood:
5	chr17:58220578..58221151-chr3:112183496..112184268,2	MCF-7	breast:
6	chr3:112011976..112013367-chr3:112237943..112239384,10	MCF-7	breast:
7	chr3:112257894..112260182-chr3:112261876..112264065,2	K562	blood:
8	chr3:112255414..112258114-chr3:112258815..112260452,2	MCF-7	breast:
9	chr3:112267834..112269856-chr3:112273355..112275580,2	MCF-7	breast:
10	chr3:112262046..112263985-chr3:112278635..112280484,2	K562	blood:
11	chr11:65325880..65326380-chr3:112226218..112226735,2	Hela-S3	cervix:
12	chr3:112045532..112046934-chr3:112156222..112157470,7	MCF-7	breast:
13	chr3:112046007..112046874-chr3:112156015..112156737,3	MCF-7	breast:
14	chr3:112045750..112047025-chr3:112237531..112238950,15	MCF-7	breast:
15	chr3:112045925..112046858-chr3:112237972..112238492,2	K562	blood:
16	chr3:112268324..112269882-chr3:112359880..112361529,2	MCF-7	breast:
17	chr3:112265348..112267048-chr3:112278268..112281074,2	K562	blood:
18	chr3:112011899..112013194-chr3:112237762..112239193,5	MCF-7	breast:
19	chr3:111830383..111831315-chr3:112250332..112250864,2	K562	blood:
20	chr3:112259312..112262688-chr3:112264103..112268109,5	MCF-7	breast:
21	chr3:112253490..112256363-chr3:112279039..112281187,3	K562	blood:
22	chr3:112215809..112217939-chr3:112219323..112221326,2	K562	blood:
23	chr3:112046305..112046882-chr3:112237913..112238884,3	MCF-7	breast:
24	chr3:112255866..112257509-chr3:112258178..112260464,2	K562	blood:
25	chr3:112257078..112259281-chr3:112279236..112282506,3	MCF-7	breast:
26	chr3:112012262..112013019-chr3:112156556..112157096,2	MCF-7	breast:
27	chr3:112215809..112217939-chr3:112219323..112221326,2	K562	blood:
28	chr3:112052345..112054034-chr3:112155349..112157049,2	MCF-7	breast:
29	chr3:112265548..112268745-chr3:112278905..112281998,3	K562	blood:
30	chr3:112259312..112262688-chr3:112264103..112268109,5	MCF-7	breast:
31	chr3:111856051..111856906-chr3:112237978..112238501,2	MCF-7	breast:
32	chr3:111830414..111830964-chr3:112156344..112156927,2	MCF-7	breast:
33	chr3:112270443..112273330-chr3:112277844..112281278,5	MCF-7	breast:
34	chr3:112250901..112252598-chr3:112279157..112281596,2	MCF-7	breast:
35	chr3:111830661..111831289-chr3:112238353..112238915,2	K562	blood:
36	chr3:112189206..112190998-chr3:112191867..112193876,2	K562	blood:
37	chr3:112030207..112032434-chr3:112262315..112264380,2	K562	blood:
38	chr3:112257611..112259171-chr3:112300442..112301943,2	K562	blood:
39	chr3:112267679..112269481-chr3:112276502..112278431,2	MCF-7	breast:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BTLA-4	chr3:112178630-112179297	NONHSAT091178
2	lnc-ATG3-3	chr3:112184773-112185230	NONHSAT091179
3	lnc-ATG3-3	chr3:112188819-112188869	NONHSAT091179
4	lnc-ATG3-3	chr3:112188603-112188651	NONHSAT091180
5	lnc-ATG3-3	chr3:112188819-112189300	NONHSAT091180
6	lnc-ATG3-3	chr3:112188605-112188651	NONHSAT091179
7	lnc-ATG3-1	chr3:112244395-112246989	NONHSAT091182
8	lnc-BTLA-4	chr3:112179309-112179627	NONHSAT091178
9	lnc-BTLA-4	chr3:112148802-112149477	NONHSAT091178

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	ATG3	hsa-miR-155-5p	chr3:112251414-112251436

Variant related genes	Relation type
ATG3	TF binding region
BTLA	TF binding region
OR7E100P	TF binding region
ATG3	CpG island
BTLA	CpG island
OR7E100P	CpG island
ENSG00000138459	chromatin interactions
ENSG00000144848	chromatin interactions
ENSG00000186265	chromatin interactions
ENSG00000172139	chromatin interactions
ENSG00000091986	chromatin interactions
CHUK	miRNA target sites

Extended variants
information (count: 4687 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:4687 , 50 per page) page: 1 2 3 4 5 6 7 ... 94

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9847446	chr3:112144026-112144027	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs534917026	chr3:112144108-112144109	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs2633546	chr3:112144152-112144153	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs114789683	chr3:112144182-112144183	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs188007102	chr3:112144237-112144238	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs180959964	chr3:112144265-112144266	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs2683890	chr3:112144295-112144296	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs576841151	chr3:112144331-112144332	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs963541	chr3:112144341-112144342	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs559390480	chr3:112144363-112144364	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs139214603	chr3:112144368-112144369	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs111403377	chr3:112144438-112144439	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs561745665	chr3:112144478-112144479	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs2683891	chr3:112144518-112144519	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs550711422	chr3:112144533-112144534	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs570122919	chr3:112144565-112144566	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs570434605	chr3:112144597-112144598	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs539067580	chr3:112144614-112144615	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs376538517	chr3:112144619-112144620	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs537756351	chr3:112144620-112144621	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs559278014	chr3:112144659-112144660	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs2683892	chr3:112144681-112144682	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs1473485	chr3:112144729-112144730	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs544783684	chr3:112144746-112144747	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs535220394	chr3:112144773-112144774	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs573458231	chr3:112144815-112144816	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs554768397	chr3:112144870-112144871	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs187274667	chr3:112144899-112144900	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs537110745	chr3:112144911-112144912	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs553229926	chr3:112144919-112144920	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs557054661	chr3:112144928-112144929	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs576779242	chr3:112144988-112144989	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs545886414	chr3:112145032-112145033	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs559588822	chr3:112145033-112145034	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs373732533	chr3:112145069-112145070	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs541992613	chr3:112145071-112145072	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs192113715	chr3:112145080-112145081	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs75767233	chr3:112145095-112145096	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs550648204	chr3:112145099-112145100	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs181815681	chr3:112145129-112145130	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs186584981	chr3:112145159-112145160	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs111570202	chr3:112145205-112145206	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs566344760	chr3:112145220-112145221	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs2683893	chr3:112145231-112145232	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs548489496	chr3:112145246-112145247	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs568288630	chr3:112145247-112145248	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs371542532	chr3:112145364-112145365	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs146412371	chr3:112145430-112145431	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs556996893	chr3:112145439-112145440	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs114145961	chr3:112145443-112145444	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Hirschsprung''s Disease	21712996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Neurodevelopmental disorder	22521361	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
microdeletion syndrome	22180640	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Developmental delay	22180640	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Basal cell lymphoma	21115979	CNVD
Attention deficit hyperactivity disorder	22180640	CNVD
Chordoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:1921 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:112132800-112144200	Weak transcription	Primary B cells from peripheral blood	blood
2	chr3:112137000-112150400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
3	chr3:112137200-112147200	Weak transcription	Placenta	Placenta
4	chr3:112138200-112145000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr3:112142200-112145000	Weak transcription	H9 Cell Line	embryonic stem cell
6	chr3:112142400-112144200	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr3:112142400-112145600	Enhancers	HUES64 Cell Line	embryonic stem cell
8	chr3:112142600-112145000	Enhancers	iPS-18 Cell Line	embryonic stem cell
9	chr3:112142600-112145600	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr3:112143000-112146200	Enhancers	Primary B cells from cord blood	blood
11	chr3:112143200-112144400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr3:112143200-112144400	Enhancers	Primary hematopoietic stem cells	blood
13	chr3:112143200-112144400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr3:112143400-112144200	Weak transcription	GM12878-XiMat	blood
15	chr3:112143400-112144800	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr3:112143400-112145000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
17	chr3:112143600-112144800	Active TSS	iPS-15b Cell Line	embryonic stem cell
18	chr3:112143600-112145200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
19	chr3:112144000-112144600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
20	chr3:112144200-112145400	Enhancers	H1 Cell Line	embryonic stem cell
21	chr3:112144200-112145600	Enhancers	GM12878-XiMat	blood
22	chr3:112144200-112146400	Enhancers	Primary B cells from peripheral blood	blood
23	chr3:112144400-112145600	Enhancers	Primary hematopoietic stem cells short term culture	blood
24	chr3:112144400-112150400	Weak transcription	Primary hematopoietic stem cells	blood
25	chr3:112144600-112144800	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr3:112144800-112145200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
27	chr3:112144800-112145400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
28	chr3:112144800-112145400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
29	chr3:112144800-112145600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr3:112145000-112145200	Flanking Active TSS	H9 Cell Line	embryonic stem cell
31	chr3:112145000-112145400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
32	chr3:112145000-112145400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
33	chr3:112145000-112145400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr3:112145000-112145600	Enhancers	Monocytes-CD14+_RO01746	blood
35	chr3:112145000-112146800	Enhancers	Primary monocytes fromperipheralblood	blood
36	chr3:112145200-112145400	Active TSS	H9 Cell Line	embryonic stem cell
37	chr3:112145200-112145400	Active TSS	HUES48 Cell Line	embryonic stem cell
38	chr3:112145200-112145400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr3:112145400-112145600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
40	chr3:112145400-112145600	Enhancers	iPS-15b Cell Line	embryonic stem cell
41	chr3:112145400-112146400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr3:112145400-112151000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
43	chr3:112145600-112146000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
44	chr3:112145600-112150400	Weak transcription	GM12878-XiMat	blood
45	chr3:112145600-112150600	Weak transcription	HUES48 Cell Line	embryonic stem cell
46	chr3:112145600-112150800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
47	chr3:112146000-112146800	Enhancers	Primary hematopoietic stem cells short term culture	blood
48	chr3:112146200-112149800	Weak transcription	Primary B cells from cord blood	blood
49	chr3:112146400-112146600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr3:112147200-112147400	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links